Rx Air Warning Cites Eight cGMP Observations

The GMP Letter
Rx Air, a Texas-based maker of massive medical air purifiers, was handed an FDA warning letter with eight observations, including lack of established procedures for validating filter tests.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00